about
Aquaporin-4 inhibition mediates piroxicam-induced neuroprotection against focal cerebral ischemia/reperfusion injury in rodentsTreatment of unruptured intracranial aneurysms: a review.Large animal canine endovascular ischemic stroke models: A review.Diabetic nephropathy: New insights into established therapeutic paradigms and novel molecular targets.Recent Advances in Oncological Submissions of Dendrimer.Resveratrol inhibits matrix metalloproteinases to attenuate neuronal damage in cerebral ischemia: a molecular docking study exploring possible neuroprotectionPiroxicam-mediated modulatory action of 5-hydroxytryptamine serves as a "brake" on neuronal excitability in ischemic strokeMesenchymal Stem Cell Therapy in Ischemic Stroke: A Meta-analysis of Preclinical Studies.Melatonin protects against behavioral deficits, dopamine loss and oxidative stress in homocysteine model of Parkinson's disease.Getting Closer to an Effective Intervention of Ischemic Stroke: The Big Promise of Stem Cell.Hypercholesterolemia causes psychomotor abnormalities in mice and alterations in cortico-striatal biogenic amine neurotransmitters: Relevance to Parkinson's disease.Inhibition of matrix metalloproteinase-2 and 9 by Piroxicam confer neuroprotection in cerebral ischemia: an in silico evaluation of the hypothesis.Neuroprotective potential of Piroxicam in cerebral ischemia: an in silico evaluation of the hypothesis to explore its therapeutic efficacy by inhibition of aquaporin-4 and acid sensing ion channel1a.Cognitive effects of NSAIDs in cerebral ischemia: a hypothesis exploring mechanical action mediated pharmacotherapy.Alleviation of glutamate mediated neuronal insult by piroxicam in rodent model of focal cerebral ischemia: a possible mechanism of GABA agonism.An in-silico strategy to explore neuroprotection by quercetin in cerebral ischemia: a novel hypothesis based on inhibition of matrix metalloproteinase (MMPs) and acid sensing ion channel 1a (ASIC1a).Minocycline and magnesium in combination may be a good therapeutic intervention for cerebral ischemia.Does Piroxicam really protect ischemic neurons and influence neuronal firing in cerebral ischemia? An exploration towards therapeutics.Combination therapy of ifenprodil with piroxicam may be an effective therapeutic intervention in cerebral stroke: a hypothesis.Noncoding RNAs in ischemic stroke: time to translate.Melatonin renders neuroprotection by protein kinase C mediated aquaporin-4 inhibition in animal model of focal cerebral ischemia.A possible therapeutic potential of quercetin through inhibition of μ-calpain in hypoxia induced neuronal injury: a molecular dynamics simulation study.Nicotine Alters Estrogen Receptor-Beta-Regulated Inflammasome Activity and Exacerbates Ischemic Brain Damage in Female Rats.Novel Targets for Parkinson's Disease: Addressing Different Therapeutic Paradigms and ConundrumsTherapeutic spectrum of interferon-β in ischemic strokeThe multiple protective roles and molecular mechanisms of melatonin and its precursor N-acetylserotonin, in targeting brain injury and liver damage and in maintaining bone healthTrigonelline therapy confers neuroprotection by reduced glutathione mediated myeloperoxidase expression in animal model of ischemic strokeGrowing synergy of nanodiamonds in neurodegenerative interventionsWhole Body Vibration Therapy after Ischemia Reduces Brain Damage in Reproductively Senescent Female RatsNeurological sequel of chronic kidney disease: From diminished Acetylcholinesterase activity to mitochondrial dysfunctions, oxidative stress and inflammation in mice brainNeuroprotective attributes of L-theanine, a bioactive amino acid of tea, and its potential role in Parkinson's disease therapeuticsGarcinol, a multifaceted sword for the treatment of Parkinson's diseaseA novel digital method to assess air space loss associated with acute lung injury in experimental acute pancreatitisInflammasomes in stroke: a triggering role for acid-sensing ion channelsExposure to hypoglycemia and risk of strokeMitochondrial Dysfunction in Stroke: Implications of Stem Cell TherapyDendrimer grafted albumin nanoparticles for the treatment of post cerebral stroke damages: A proof of concept studyEvolving Evidence of Calreticulin as a Pharmacological Target in Neurological DisordersA Friend or Foe: Calcineurin across the Gamut of Neurological DisordersCell Death Pathways in Ischemic Stroke and Targeted Pharmacotherapy
P50
Q28536674-D93BEC11-DA30-4C13-92B3-25074495FE94Q38854358-A70AB917-37FA-4B02-AB76-2D125701BF90Q38919990-9BA21E2D-1368-45B0-85C4-C335ACACD7CAQ39156314-542D718F-A992-4BDF-9D11-D9989F4A6810Q39207218-C85ED59D-E907-4B03-AF9C-954B9D27585DQ40445535-9FFD8C96-B668-4FCD-A0EF-FE7EB4276450Q41959116-20A8AF29-F9CF-4120-BA29-A65D6D5AB688Q46271091-23D1FC1A-7357-4D5B-9373-D298EFA8EF2BQ47402522-DB204282-3D25-4767-B86C-3398B4D63FD6Q47405412-59E2E852-853E-4777-AF98-CFC5D9EE3856Q47975815-BD124772-B338-4E9D-B36B-F30D6D9150FEQ48430442-3B8EDA84-5B90-4FEB-BCB9-66B66F3F1562Q48440585-D967948F-81BC-4CBE-9DB8-B1C784AD27CEQ48448974-1B1426D4-C042-44EA-A373-BD400E3EB10FQ48493656-77F2EBDA-E659-4AC1-9768-B0A63D15E01AQ48541930-9107849F-5F14-46E5-96A4-7845E6D50FB1Q48853357-DE3AC313-FE2C-40A4-A92B-3EA815D3D73BQ51798179-54B172B2-CEEE-4983-95B9-1BEDE6F96666Q52301315-CB425D1E-683D-434B-9CB8-29B0185B7392Q52570379-DC7123D9-5C92-438E-9D28-B915F2D42D26Q53619868-4BC8B6D2-B833-4ABF-86DE-24A5576BA582Q54966145-65FA7933-2A95-4DDA-BA41-C85B25CD1E46Q55356075-BB92F7F4-69EB-45B0-8B48-D6C7215B87CEQ57176356-103456AC-5BCA-46AF-88B7-E3450F9CBBD4Q57464040-2C0C7DF3-EBFE-4CF5-9D92-3D6C58E519E4Q57478099-20D44D24-5FA0-4573-9893-2181D061CF33Q58598913-421AFCF5-50C6-4514-8773-253020A98887Q58610030-CCFDF6CE-8DCF-41C6-ACF0-0961A982D241Q58742390-63EF02DA-9B7F-460F-949A-168444ACC48BQ64092898-67CAAFEB-C475-4762-8690-B8BC8B004907Q64764676-F3F7D932-D8C4-4253-BA2E-CFB13ECA69ACQ64768776-6FF28B42-551D-4E7B-811C-AD2830259726Q88763009-98D06F99-6819-40A6-BAB9-1849BE0B6DA4Q89149588-4F23DEBF-FDA8-4DD1-BAF4-A4EF36FD3FF8Q89149591-DA4693D5-5619-4C24-BC28-ABC602BF14FEQ89172402-8B224619-7366-4D90-844C-69F25D590B4CQ90200320-C5EFE326-D48D-444F-95F8-35DA1F44A5A9Q90267748-A181B3EA-6D29-4E8C-BB7D-AE9C637972C8Q90652114-DA6CFD8F-DA33-4684-A649-A10B1C8DC4D0Q90704138-3201CC27-9813-4FA7-BD3D-1E596B4E5FD7
P50
description
neuroscientist
@en
onderzoeker
@nl
name
Pallab Bhattacharya
@ast
Pallab Bhattacharya
@en
Pallab Bhattacharya
@es
Pallab Bhattacharya
@nl
Pallab Bhattacharya
@sl
পল্লব ভট্টাচার্য
@bn
type
label
Pallab Bhattacharya
@ast
Pallab Bhattacharya
@en
Pallab Bhattacharya
@es
Pallab Bhattacharya
@nl
Pallab Bhattacharya
@sl
পল্লব ভট্টাচার্য
@bn
prefLabel
Pallab Bhattacharya
@ast
Pallab Bhattacharya
@en
Pallab Bhattacharya
@es
Pallab Bhattacharya
@nl
Pallab Bhattacharya
@sl
পল্লব ভট্টাচার্য
@bn
P1153
52363195500
P31
P496
0000-0003-2867-1650